Aug 10, 2023 / 09:00AM GMT
Operator
Ladies and gentlemen, good day, and welcome to Q1 FY24 earnings conference call of JB Pharma. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Jason D'Souza, Executive Vice President of JB Pharma. Thank you and over to you, sir.
Jason D'Souza - JB Chemicals & Pharmaceuticals Ltd. - EVP
Thank you, Nirav. Welcome to the earnings call of JB Pharma. We have with us today, Nikhil Chopra, CEO and Whole Time Director; Kunal Khanna, President, Operations; and Lakshay Kataria, Chief Financial Officer at JB Chemicals and Pharmaceuticals Limited.
Before we begin, I would like to state that some of the statements in today's discussion may be forward-looking in nature and may involve certain risks and uncertainties. A detailed statement in this regard is available in the Q1 FY24 investor presentation that has been sent to you earlier.
I would like to hand over the floor to Mr. Nikhil Chopra to begin the proceedings of the call for his opening comments, after
Q1 2024 J B Chemicals and Pharmaceuticals Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot